Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results

Kips Bay Medical, Inc. (KIPS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/22/2015 8-K Quarterly results
09/10/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/06/2015 DEF 14A Form DEF 14A - Other definitive proxy statements
08/06/2015 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results MINNEAPOLIS, MN, August 6, 2015 –Kips Bay Medical, Inc. , a medical device company that was focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 27, 2015. Feasibility Study and Business Update"
08/06/2015 10-Q Quarterly Report for the period ended June 27, 2015
07/24/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between Kips Bay Medical, Inc. and Manual Villafaña (Filed herewith)",
"Letter Agreement between Kips Bay Medical, Inc. and Scott Kellen (Filed herewith)"
07/24/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/29/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Plan of Dissolution and Complete Liquidation of Kips Bay Medical, Inc. (Filed herewith)",
"Kips Bay Medical Announces an Orderly Wind Down of Operations with the Termination of"
06/29/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/12/2015 8-K Quarterly results
Docs: "Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results MINNEAPOLIS, MN, May 12, 2015 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a clinical trial update and announced financial results for its first quarter ended March 28, 2015. Feasibility Study Update"
05/12/2015 10-Q Quarterly Report for the period ended March 28, 2015
04/15/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
04/15/2015 4/A LaBounty Randall Keith (VP of Reg. & Clinical Affairs) has filed a Form 4 on Kips Bay Medical, Inc.
04/15/2015 4/A VILLAFANA MANUEL A (Chairman of the Board and CEO) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 75,000 options to buy @ $0
04/15/2015 4/A Kellen Scott (COO, CFO, VP of Finance & Secy) has filed a Form 4 on Kips Bay Medical, Inc.
03/24/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Form of Warrant to Purchase Shares of Common Stock of Kips Bay Medical, Inc. (Filed herewith)",
"Securities Purchase Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Registration Rights Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Employment Agreement, effective as of July 1, 2015, by and between Kips Bay Medical, Inc. and Manuel A. Villafaña (Filed herewith)",
"Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing"
03/12/2015 4 VILLAFANA MANUEL A (Chairman of the Board and CEO) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 75,000 options to buy @ $0.24, valued at $18k
03/12/2015 4 Kellen Scott (COO, CFO, VP of Finance & Secy) has filed a Form 4 on Kips Bay Medical, Inc.
03/12/2015 4 LaBounty Randall Keith (VP of Reg. & Clinical Affairs) has filed a Form 4 on Kips Bay Medical, Inc.
03/12/2015 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Kips Bay Medical Announces Achievement of Enrollment Goal and Provides Business Update and Fourth Quarter and Full Year 2014 Results"
03/12/2015 10-K Annual Report for the period ended December 31, 2014
01/21/2015 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/06/2015 4 VILLAFANA MANUEL A (Chair of the Board and CEO) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 75,000 options to buy @ $0.18, valued at $13.5k
01/06/2015 4 LaBounty Randall Keith (VP of Reg. & Clinical Affairs) has filed a Form 4 on Kips Bay Medical, Inc.
01/06/2015 4 Kellen Scott (COO, CFO, VP of Finance & Secy) has filed a Form 4 on Kips Bay Medical, Inc.
01/06/2015 4/A Smith Arch C (Director) has filed a Form 4 on Kips Bay Medical, Inc.
01/06/2015 4/A MUNZENRIDER ROBERT E (Director) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 45,000 options to buy @ $0
01/06/2015 4/A Sheehy Robert J (Director) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 45,000 options to buy @ $0
01/05/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Kips Bay Medical Reorganizes Operations and Reduces Staff to Focus on Clinical Study Work and Conserve Capital"
12/12/2014 4 Sheehy Robert J (Director) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 45,000 options to buy @ $0.12, valued at $5.4k
12/12/2014 4 Smith Arch C (Director) has filed a Form 4 on Kips Bay Medical, Inc.
12/12/2014 4 MUNZENRIDER ROBERT E (Director) has filed a Form 4 on Kips Bay Medical, Inc.
Txns: Granted 45,000 options to buy @ $0.12, valued at $5.4k
11/06/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Feasibility Study Update and Reports Third Quarter 2014 Results MINNEAPOLIS, MN, November 6, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its third quarter ended September 27, 2014. Feasibility Study Update"
11/06/2014 10-Q Quarterly Report for the period ended September 27, 2014
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy